5-methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling.
BACKGROUND: The circulating form of folic acid, 5-methyltetrahydrofolate (5-MTHF), may have beneficial effects on endothelial function; however, its mechanisms of action remain uncertain. Decreased nitric oxide (NO) bioavailability and increased vascular superoxide production in vascular disease sta...
Prif Awduron: | Antoniades, C, Shirodaria, C, Warrick, N, Cai, S, de Bono, J, Lee, J, Leeson, P, Neubauer, S, Ratnatunga, C, Pillai, R, Refsum, H, Channon, K |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
2006
|
Eitemau Tebyg
-
5-Methyl-tetrahydrofolate acid improves endothelial function and decreases superoxide production by improving eNOS coupling and increasing tetrahydrobiopterin bioavailability in human vessels in vivo
gan: Antoniades, C, et al.
Cyhoeddwyd: (2006) -
Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis.
gan: Antoniades, C, et al.
Cyhoeddwyd: (2009) -
The common genetic polymorphism C677T of methyltetrahydrofolate reductase regulates nitric oxide bioavailability and vascular superoxide production via modulation of eNOS coupling in human vessels
gan: Antoniades, C, et al.
Cyhoeddwyd: (2007) -
5-methyl-tetrahydrofolic acid increases nitric oxide bioavailability and decreases superoxide production by improving eNOS coupling in human vessels in vivo: Effects on intracellular tetrahydrobiopterin oxidation
gan: Antoniades, C, et al.
Cyhoeddwyd: (2006) -
Low- and high- dose treatment with folic acid, equally improve endothelial function and decrease superoxide production in human vessels via tetrahydrobiopterin-mediated eNOS coupling
gan: Antoniades, C, et al.
Cyhoeddwyd: (2007)